Nearly 60% of Americans express interest in genetic testing

Interest in whole-genome sequencing varies among Americans, but parents who are interested in sequencing for themselves are equally interested in it for their children, according to a study published in Public Health Genomics.

Advertisement

Researchers provided basic information about whole-genome sequencing to study participants who were then asked about their interest in it for themselves and their children.

Highlighted below are five findings from the study:

  • Nearly 59 percent of the total participants — both parents and nonparents — expressed interest in whole-genome sequencing for themselves.
  • Among parents, 61.8 percent were interested in it for themselves and 58 percent of parents were interested in whole-genome sequencing for their youngest children.
  • Close to 85 percent of parents expressed an identical interest level in whole-genome sequencing for themselves and their youngest children.
  • Mothers and parents whose youngest children had two or more health conditions expressed considerably more interest in sequencing for themselves and their children than nonparents and parents of children without health conditions.
  • Individuals who identified themselves as more conservative had considerably less interest in whole-genome sequencing.

 

 

More articles on genetics:
UCLA to pilot inclusion of genomic data in EHR
NorthShore University HealthSystem: A trailblazer in precision medicine
Researchers to use ‘Internet of genomics’ to treat orphan diseases

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Care Coordination

Advertisement

Comments are closed.